Hyperspectral imaging of the early embryo: can it detect chromosome abnormalities and predict IVF success? (Conference Presentation)

Kylie R. Dunning; Carl A. Campugan; Tiffany C. Y. Tan; Saabah B. Mahbub; Ewa M. Goldys; Jeremy G Thompson

doi:10.1117/12.2510912

4 March 2019 Hyperspectral imaging of the early embryo: can it detect chromosome abnormalities and predict IVF success? (Conference Presentation)

Kylie R. Dunning, Carl A. Campugan, Tiffany C. Y. Tan, Saabah B. Mahbub, Ewa M. Goldys, Jeremy G Thompson

Author Affiliations +

Proceedings Volume 10890, Label-free Biomedical Imaging and Sensing (LBIS) 2019; 108900I (2019) https://doi.org/10.1117/12.2510912
Event: SPIE BiOS, 2019, San Francisco, California, United States

Abstract

Despite its wide-spread use, the success rate of assisted reproductive technologies including IVF is less than 20% in Australia/New Zealand. Most early human embryos are mosaic for chromosome abnormalities, containing a proportion of normal and abnormal cells. The most common chromosomal abnormality is aneuploidy: incorrect number of chromosomes. This form of mosaicism is thought account for early pregnancy loss in IVF. Current single cell biopsies of embryos are not diagnostic for the proportion of cells that are aneuploid (degree of heterogeneity/mosaicism). Thus, development of a non-invasive tool to determine the proportion of aneuploid cells facilitating segregation of embryos with a low percentage of aneuploid cells would likely improve IVF success rates. In other cells, including cancer cells, aneuploidy results in altered cellular metabolism. In this study we utilised hyperspectral imaging as a means of non-invasively measuring cellular metabolism in the early embryo. We utilised a mouse model where we manipulated the ratio of aneuploid:normal cells. Aneuploid embryos were generated by treatment during division from 4 to 8 cells using a reversible spindle assembly check point inhibitor, reversine. Eight-cell aneuploid embryos were dissociated and joined with control/normal cells to generate 1:1 aneuploid:normal chimeras. Hyperspectral imaging of 1:1 chimeric embryos had a distinct spectral profile that varied dramatically from the control/normal embryos. Interestingly, entirely aneuploid embryos showed a spectral profile dissimilar from both normal and chimeric embryos. These data show hyperspectral imaging is capable of distinguishing between embryos with varying degrees of aneuploidy making it a promising tool in assessing embryo health.

Conference Presentation

Citation Download Citation

Kylie R. Dunning, Carl A. Campugan, Tiffany C. Y. Tan, Saabah B. Mahbub, Ewa M. Goldys, and Jeremy G Thompson "Hyperspectral imaging of the early embryo: can it detect chromosome abnormalities and predict IVF success? (Conference Presentation)", Proc. SPIE 10890, Label-free Biomedical Imaging and Sensing (LBIS) 2019, 108900I (4 March 2019); https://doi.org/10.1117/12.2510912

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available